Daiichi Sankyo (Switzerland) jobs and careers
About Daiichi Sankyo (Switzerland)
Daiichi Sankyo is dedicated to the creation and supply of innovative pharmaceutical products to address the diversified, unmet medical needs of patients in both mature and emerging markets. While maintaining its portfolio of marketed pharmaceuticals for hypertension, hyperlipidemia and bacterial infections, Daiichi Sankyo is also engaged in the development of treatments for thrombotic disorders and focuses on the discovery of novel oncology and cardiovascular-metabolic therapies. The company's roots extend back to 1899 and the early days of industrialisation of the pharmaceutical sector. The company was created in 2005 through the merger of two traditional Japanese enterprises, Daiichi and Sankyo. Daiichi Sankyo's world headquarters are in Tokyo, Japan, and its European base is located in Munich, Germany. The company does business in nearly 60 countries around the world, including 12 European countries. Daiichi Sankyo has been one of the strongest Japanese pharmaceutical companies located in Europe since it set up its European production facilities and marketing offices in 1990.
- Employees
- 11 to 50
Leadership
The top of Daiichi Sankyo (Switzerland)'s org chart, with how many people report into each leader.
Masahiro Shibasaki
Managing Director
38 reports
Giuseppe Grossi
General Manager
17 reports
Erkan Ünal
Medical Affairs Lead Speciality Business Division
9 reports
Dominic P. Zahn
Head of Market Access
1 report
Alphonse Mordiva
Sr. Director, Head R&d Quality Europe
1 report
Kristin Beyer
Head Of HR
1 report
Alexandra Wirz
Regulatory Affairs Lead
1 report
Alexander Fuchs
Director Legal & Compliance
Maximilian Mucha
Head of Finance
Jobs at Daiichi Sankyo (Switzerland)
No open positions right now. Explore more companies on TheJobsMap.